Health TrialsbyHealthPanel

AnovaOS Network Powered Patient Registry

ConditionsInfectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural DisordersDiseases of the Nervous SystemDiseases of the Eye and AdnexaDiseases of the Ear and Mastoid ProcessDiseases of the Circulatory SystemDiseases of the Respiratory SystemDiseases of the Digestive SystemDiseases of the Skin and Subcutaneous TissueDiseases of the Musculoskeletal System and Connective TissueDiseases of the Genitourinary SystemPregnancy, Childbirth and the PuerperiumCertain Conditions Originating in the Perinatal PeriodCongenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere ClassifiedInjury, Poisoning and Certain Other Consequences of External CausesExternal Causes of Morbidity and MortalityFactors Influencing Health Status and Contact With Health Services
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAnova Enterprises, Inc

About this trial

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years old or older;

Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;

Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;

Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;

Disqualifiers

Subjects who do not meet the inclusion criteria for the study;

Subjects who are unable to understand the protocol or unable to provide legally effective informed consent

Trial population

Real-world clinical data about patients with complex, serious or immediately life-threatening disease collected as part of the AnovaOS™ platform is important to the scientific community. These data support biopharmaceutical companies, academic researchers and other sponsors with program design and prioritization, study activation and enrolment, and study conduct to help advance promising new therapeutic approaches. Learning from real-world evidence can help inform drug development and help as our research system evolves from a traditional model to one capable of recognizing the benefits of precision medicine. The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in on patients with complex disease globally.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Assess Natural history

Assessing natural history, including estimating the magnitude of a problem; determining the underlying incidence or prevalence rate of a condition; examining trends of disease over time; assessing service delivery and identifying groups at high risk; and describing and estimating survival;

Time frame
5 years
2

Assess Clinical, Cost and/or Comparative Effectiveness

Determining clinical effectiveness, cost effectiveness, or comparative effectiveness of a test or a treatment;

Time frame
5 years
3

Assess Safety

Measuring and monitoring safety and harm associated with the use of specific products and treatments, including conducting comparative evaluation of safety and effectiveness;

Time frame
5 years
4

Measuring and/or Improving Quality of Care

Measuring or improving quality of care, including conducting programs to measure and/or improve the practice of medicine and/or public health.

Time frame
5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Anova Enterprises, Inc

Lead sponsor

Source ClinicalTrials.gov
Apply now